Season 3, Episode 6: The $200 Test That Can Save $10 Billion and 10,000 Lives

The facts are staggering. Lung cancer remains the number one cancer killer of both men and women. 230,000 new lung cancer diagnoses are expected in the US this year.  The average annual cost of treating advanced or metastatic lung cancer is astronomical, often exceeding $200,000 per year. Lung cancer screening with low-dose CT scans is severely underused in the U.S. with less than 20% of the millions of eligible high-risk former and current smokers getting tested. Lung cancer screening works.  It’s safe and effective. It saves lives. It saves healthcare dollars as the cost of treating advanced cancer continues to skyrocket.  On this episode, we'll try to understand how to increase use of this inexpensive test that can save more lives and money than any other in healthcare.